• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Achillion Pharmaceuticals Inc

+ Add to Watchlist

ACHN:US

2.8300 USD 0.0400 1.43%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Achillion Pharmaceuticals Inc (ACHN)

Open: 2.7900 Day's Range: 2.7100 - 2.9000 Volume: 961,150
Previous Close: 2.7900 52wk Range: 2.2600 - 8.4900 1-Yr Rtn: -62.06%

Stock Chart for ACHN

No chart data available.
  • ACHN:US 2.8300
  • 1D
  • 1M
  • 1Y
2.7900
Interactive ACHN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACHN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6300
Est. EPS (USD) (12/2014) -0.7490
Est. PEG Ratio -
Market Cap (M USD) 273.92
Shares Outstanding (M) 96.79
30 Day Average Volume 1,758,116
Price/Book (mrq) 1.7908
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACHN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACHN

Achillion Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops solutions for infectious diseases such as HIV, hepatitis, and resistant bacterial infections.

Milind S DeshpandePresident/CEOMary Kay FentonExec VP/CFO
Gautam ShahExec VP/Chief Compliance OfcrJoseph TruittExec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for ACHN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil